Results 91 to 100 of about 744,029 (294)
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund +3 more
wiley +1 more source
Introduction With the increasing use of recombinant α and β interferon therapy for the treatment of various disorders, cases of interferon-associated sarcoidosis have been reported in the literature.
Petousi Nayia, Thomas Enson C
doaj +1 more source
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo +9 more
wiley +1 more source
Adult‐Onset Subacute Sclerosing Panencephalitis Presenting With Subacute Cognitive Deficits
ABSTRACT We describe the case of a 41‐year‐old man diagnosed with adult‐onset subacute sclerosing panencephalitis (SSPE). The patient presented with subacute progressive cognitive deficits and a neuropsychological profile indicating predominant frontoparietal dysfunction. MRI showed only mild parietal‐predominant cerebral atrophy.
Dennis Yeow +4 more
wiley +1 more source
Antecedentes: El H. pylori es el principal factor de riesgo para el desarrollo de gastritis crónica, úlcera gástrica y cáncer gástrico. El resultado clínico en infectados por esta bacteria depende de varios factores, entre ellos los componentes ...
D.N. Martínez-Carrillo +8 more
doaj +1 more source
Enfermedades por inmunosupresión asociadas al virus de la leucemia felina [PDF]
Este trabajo trata de resaltar la importancia del síndrome de inmunosupresión/mielosupresión inducido por el virus de la leucemia felina (FeLV), frente a la patología tumoral más característica y divulgada.
Camacho Quesada, Mª S. +2 more
core
Immune‐Driven Expression in Inclusion Body Myositis With T‐Cell Large Granular Lymphocytic Leukemia
ABSTRACT Objectives T‐cell large granular lymphocytic leukemia (T‐LGLL), reported in up to 58% of inclusion body myositis (IBM) patients, is a rare leukemia of cytotoxic or less commonly helper T cells. The range of myopathies in T‐LGLL and the impact of coexisting T‐LGLL in IBM are not well understood. Our objectives are to investigate the spectrum of
Pannathat Soontrapa +10 more
wiley +1 more source
Intensive Farmaco- Surveillance of Interferon Alpha 2b Recombinant in Multiple Sclerosis.
Background: The interferon alpha 2b recombinant, produced in Cuba, is used in the treatment of different illnesses, such as the multiple sclerosis. For its commercialization it is needed to know its safety scope.
Leslie Pérez Ruiz +4 more
doaj +2 more sources
Incidencia de la linfopenia en pacientes con Esclerosis Múltiple en tratamiento con Interferón beta [PDF]
La Esclerosis Múltiple se trata de una enfermedad crónica del sistema nervioso central de la cual se desconoce su causa. Se caracteriza por inflamación, desmielinización y cicatrización del tejido nervioso. Desde un punto de vista patológico, se trata
Castillo Ferrero, Raquel
core
Diagnosis of tuberculosis infection using interferon-γ-based assays [PDF]
Interferon-γ-based assays, collectively known as IFN-γ release assays (IGRAs), have emerged as a reliable alternative to the old tuberculin skin test (TST) for the immunodiagnosis of tuberculosis (TB) infection.
Aabye +100 more
core +2 more sources

